University of California, San Francisco
San Francisco, California, 94158, United States
Location status: Recruiting
NCT Number: NCT06943599
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94158, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.
Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.
Time frame: 21 days after screening
The count of participants who attend the referral visit.
Contact information is provided by the study sponsor or research team.
Jeremy Keenan, MD, MPH
CONTACT
Krisianne Aromin
CONTACT
University of California, San Francisco
Other
Village Integrated Eye Worker II Linkage-to-Care Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03076697
Age Related Macular Degeneration, Cardiovascular Diseases
View Trial DetailsNCT07318428
Age Related Macular Degeneration, Cardiovascular Diseases
Busan, South Korea
View Trial DetailsNCT03278587
Age Related Macular Degeneration, Cardiovascular Diseases
Bharatpur, Chitwan, Nepal
View Trial DetailsNCT07002372
Age Related Macular Degeneration, CYSTOID MACULAR EDEMA
Hangzhou, Zhejiang, China
View Trial Details